Fundraising Fox

Chrono Therapeutics

Hayward, US · California corporation · 5 known investors

chronothera.com ↗
Healthtech

Founders & leadership

GD
GUY DIPIERROFounder
AL
ALAN LEVY, PH.D.Executive
AR
ANTHONY RIMACExecutive
AL
ALAN LEVYNamed on SEC filing

Board

ER
ELIZABETH ROCKETTBoard directorInvestor at Kaiser Permanente Ventures
WHWENDE HUTTON
WENDE HUTTONin𝕏Board directorGeneral Partner at Canaan Partners
AK
AIDAN KINGBoard directorManaging Partner and Co-Founder at Fountain Healthcare Partners
SJ
STEVEN JAMESBoard director
JW
JAMES W. YOUNGBoard director
TK
TIM KILGALLONBoard director

Investors · 5

Emergent Medical Partners, LLPSan Jose
Fountain Healthcare PartnersDublin · $10.8M – $16.2M
Kaiser Permanente VenturesSan Francisco · $2M – $5M
Mission Bay CapitalSan Francisco
Canaan PartnersreportedStamford · $500K – $20Mvia Wende Hutton · board

Reported raises · per SEC filings

Form D private placements

$51.4M disclosed across 3 rounds · 2014–2016

▶$37.6MraisedSep 2016 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVEN JAMESDirector
  • ALAN LEVY, PH.D.Executive Officer, Director
  • GUY DIPIERRODirector
  • JAMES W. YOUNGDirector
  • ELIZABETH ROCKETTDirector
  • TIM KILGALLONDirector
  • WENDE HUTTONDirector
  • AIDAN KINGDirector
  • ANTHONY RIMACExecutive Officer
Offering amount
$47.6M
Amount sold
$37.6M
First sale
Aug 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.3MraisedJun 2014 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES W. YOUNGDirector
  • TIM KILGALLONDirector
  • ALAN LEVYExecutive Officer, Director
  • GUY DIPIERROExecutive Officer, Director
  • WENDE HUTTONDirector
Offering amount
$33.2M
Amount sold
$13.3M
Placement agents
Leerink Partners LLC
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN LEVYExecutive Officer, Director
  • GUY DIPIERROExecutive Officer, Director
Offering amount
$1M
Amount sold
$500K
Minimum investment
$50K
First sale
Feb 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$155.3K
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.8M
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$2.2M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Chrono Therapeutics?
Chrono Therapeutics was founded by GUY DIPIERRO.
Who are Chrono Therapeutics's investors?
Chrono Therapeutics's investors include Emergent Medical Partners, LLP, Fountain Healthcare Partners, Kaiser Permanente Ventures, Mission Bay Capital, Canaan Partners.
How much funding has Chrono Therapeutics raised?
Chrono Therapeutics has disclosed $51.4M raised across 3 rounds.
Where is Chrono Therapeutics headquartered?
Chrono Therapeutics is headquartered in Hayward, US.